Back to search

Article

Dihydromyricetin alleviates inflammatory bowel disease associated intestinal fibrosis by inducing autophagy through the PI3K/AKT/mTOR signaling pathway

2023-08-31

Abstract excerpt

<title>Abstract</title> <p><bold>Objective: </bold>Intestinal fibrosis is a common complication of inflammatory bowel disease and is characterized by tissue stiffening and luminal narrowing. Dihydromyricetin (DHM) can alleviate liver fibrosis and renal interstitial fibrosis by inducing autophagy. However, whether DHM can alleviate intestinal fibrosis remains unclear. This study aimed to evaluate the role and mech...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
52516b73-8251-5954-9b03-302ad7a48b03
DOI
10.21203/rs.3.rs-3305044/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Dihydromyricetin alleviates inflammatory bowel disease associated intestinal fibrosis by inducing autophagy through the PI3K/AKT/mTOR signaling pathwayDOI 10.21203/rs.3.rs-3305044/v1
Select a neighboring publication to make it the new centre.